Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,

FDA recall notice · announced May 15, 2013 · L. Perrigo Co

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,

Reason for recall

Failed Impurities/Degradation Specifications: 3 month stability testing.

Notes

Distribution: Nationwide
Lot/code information: 12K714 exp. 12/13, 12K715 exp. 12/13
Quantity: 21,667 bottles
Status: Terminated
Products in this recall event:
- Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01, (D-318-2013)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.